Skip to main content
. 2021 Aug 16;10(1):1960728. doi: 10.1080/2162402X.2021.1960728

Figure 8.

Figure 8.

Experiment workflow and proposed model of better anti-tumor efficacy after EphA2-a-CAR-T cells treatment